Cite
HARVARD Citation
Beatch, G. et al. (2017). Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region. Journal of cardiovascular pharmacology. 69 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Beatch, G. et al. (2017). Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region. Journal of cardiovascular pharmacology. 69 (2), p. . [Online].